申请人:Cellzome Limited
公开号:US20150166513A1
公开(公告)日:2015-06-18
The present invention relates to compounds of formula (I)
wherein R, R
1
, X
1
to X
5
have the meaning as cited in the description and the claims. Said compounds are useful as TYK2 inhibitors for the treatment or prophylaxis of immunological, inflammatory, autoimmune, allergic disorders, and immunologically-mediated diseases. The invention also relates to pharmaceutical compositions including said compounds as well as their use as medicaments.
本发明涉及式(I)化合物,其中R、R1、X1至X5的含义如说明书和权利要求中所述。所述化合物作为TYK2抑制剂对治疗或预防免疫、炎症、自身免疫、过敏性疾病和免疫介导疾病有用。本发明还涉及包括所述化合物的制药组合物以及它们作为药物的使用。